Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

doxorubicin 50\~60mg/m2, i.v., d1, q3w or q2w.

epirubicin 80\~100mg/m2, i.v., d1, q3w or q2w.

pirarubicin 40\~50mg/m2, i.v., d1, q3w or q2w.

cyclophosphamide 600mg/m2, i.v., d1, q3w or q2w.

albumin-bound paclitaxel 260mg/m2, i.v., d1, q3w; 260mg/m2, i.v., d1, q2w; or 125mg/m2, i.v., d1, qw.

paclitaxel 175mg/m2, i.v., d1, q3w; 175mg/m2, i.v., d1, q2w; or 80mg/m2, i.v., d1, qw.

docetaxel 80\~100mg/m2, i.v., d1, q3w.